POM-V Prescription Required Companion Animal

Meloxidolor 5 mg/ml Solution for Injection for Dogs, Cats, Cattle and Pigs

Active ingredient: Meloxicam

Form

Injection

Species

Cats Cattle Dogs Pigs

Manufacturer

Le Vet Beheer B.V.

VMD MA No.

41821/5005

What it's used for

and soft tissue surgery. Cats: Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery. Cattle: For use in acute respirator...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Meloxidolor 5 mg/ml Solution for Injection for Dogs, Cats, Cattle and Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

and soft tissue surgery.
Cats:
Reduction of post-operative pain after ovariohysterectomy and minor soft tissue
surgery.
Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to reduce
clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical
signs in calves of over one week of age.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness
and inflammation.
For the relief of post-operative pain associated with minor soft tissue surgery such as
castration.

Oral suspensions of meloxicam for dogs may be used for continuation of treatment
at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of
the injection.
Reduction of post-operative pain (over a period of 24 hours):
Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg
body weight (i.e. 0.4 ml/10 kg body weight) before surgery, for example at the time of
induction of anaesthesia.
Cats:
Reduction of post-operative pain:
Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg body weight (i.e.
0.06 ml/kg body weight) before surgery, for example at the time of induction of
anaesthesia.
Cattle:
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg
body weight (i.e.10 ml/100 kg body weight) in combination with antibiotic therapy or
with oral re-hydration therapy, as appropriate.
Pigs:
Locomotor disorders:
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e.
2 ml/25 kg body weight). If required, a second administration of meloxicam can be
given after 24 hours.
Reduction of post-operative pain:
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e.
0.4 ml/5 kg body weight) before surgery.
Particular care should be taken with regard to the accuracy of dosing including the
use of an appropriate dosing device and careful estimation of body weight.
Avoid introduction of contamination during use. The stopper should not be punctured
more than 20 times.

Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in dogs and cats suffering from gastrointestinal disorders such as
irritation and haemorrhage, impaired hepatic, cardiac or renal function and
haemorrhagic disorders.
Do not use in dogs and cats less than 6 weeks of age nor in cats of less than 2 kg.
Do not use in cattle and pigs suffering from impaired hepatic, cardiac or renal
function and haemorrhagic disorders, or where there is evidence of ulcerogenic
gastrointestinal lesions.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week
of age.
Do not use in pigs less than 2 days old.
See also section 3.7.

Dogs, cats:
Rare
(1 to 10 animals / 10,000
animals treated):
Appetite loss
a
, Lethargy
a

Vomiting
a
, Diarrhoea
a
, Blood in faeces
a,b
Renal failure
a
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Elevated liver enzymes
Haemorrhagic diarrhoea
c
, Haematemesis
c
,
Gastrointestinal ulceration
c
Anaphylactic reaction
d
a
Typical adverse reactions of NSAIDs.
b
Occult.
c
These adverse reactions occur generally within the first treatment week and are in
most cases transient and disappear following termination of the treatment but in very
rare cases may be serious or fatal.
d
Should be treated symptomatically.
Cattle:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Injection site swelling
a
Anaphylactic reaction
b
a
Following subcutaneous injection: slight and transient.
b
May be serious (including fatal) and should be treated symptomatically.
Pigs:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylactic reaction
a
a
May be serious (including fatal) and should be treated symptomatically.
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Treatment of piglets with Meloxidolor before castration reduces post-operative pain.
To obtain pain relief for cattle and pigs during surgery co-medication with an
appropriate anaesthetic/sedative/analgesic is needed.

To obtain the best possible pain relieving effect for pigs post-surgery Meloxidolor
should be administered 30 minutes before surgical intervention.
Treatment of calves with Meloxidolor 20 minutes before dehorning reduces post-
operative pain. Meloxidolor alone will not provide adequate pain relief during the
dehorning procedure.

Special precautions for safe use in the target species:
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of renal toxicity. During anaesthesia, monitoring and fluid therapy
should be considered as standard practice.
Any oral follow-up therapy using meloxicam or other Non-Steroidal Anti-Inflammatory
Drugs (NSAIDs) should not be administered in cats, as appropriate dosage regimens
for such follow-up treatments have not been established.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Accidental self-injection may give rise to pain. People with known hypersensitivity to
NSAIDs should avoid contact with the veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
The veterinary medicinal product should not be administered by pregnant women or
women of child-bearing potential as Meloxicam may be harmful to the foetus and
unborn child.
Special precautions for the protection of the environment:
Not applicable.

For dogs and cats:
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances
with high protein binding may compete for binding and thus lead to toxic effects.
Meloxidolor must not be administered in conjunction with other NSAIDs or
glucocorticosteroids. Concurrent administration of potential nephrotoxic veterinary
medicinal products should be avoided. In animals at anaesthetic risk (e.g. aged
animals) intravenous or subcutaneous fluid therapy during anaesthesia should be
taken into consideration. When anaesthesia and NSAID are concomitantly
administered, a risk for renal function cannot be excluded.
Pre-treatment with anti-inflammatory substances may result in additional or
increased adverse effects and accordingly a treatment-free period with such
veterinary medicinal products should be observed for at least 24 hours before
commencement of treatment. The treatment-free period, however, should take into
account the pharmacological properties of the products used previously.
For cattle and pigs:
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-
inflammatory drugs or with anticoagulant agents.

This veterinary medicinal product does not require any special storage conditions.

Cattle: Meat and offal: 15 days
Pigs: Meat and offal: 5 days

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.